| Serial Number | 97151041 |
| Word Mark | C-SRRNA |
| Filing Date | Wednesday, December 1, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 12, 2023 |
| Registration Number | 7243728 |
| Registration Date | Tuesday, December 12, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 9, 2023 |
| Goods and Services | Dosage medium preparations, namely, pharmaceutical preparations for the treatment and prevention of infectious diseases, cancer, and aging-related diseases; vaccines; regenerative medicine, namely, pharmaceuticals for cell rejuvenation |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, July 6, 2023 |
| First Use In Commerce Date | Thursday, July 6, 2023 |
| Party Name | Elixirgen Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Baltimore, MD 21205 |
| Party Name | Elixirgen Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Baltimore, MD 21205 |
| Party Name | Elixirgen Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Baltimore, MD 21205 |
| Event Date | Event Description |
| Tuesday, December 12, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 12, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 7, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Saturday, November 4, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, August 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 22, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, August 15, 2023 | USE AMENDMENT FILED |
| Tuesday, August 22, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, August 15, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, August 22, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, August 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 15, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, July 4, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 9, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 9, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 4, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 19, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 19, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 19, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 19, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 19, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, September 19, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, September 10, 2022 | ASSIGNED TO EXAMINER |
| Monday, December 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 4, 2021 | NEW APPLICATION ENTERED |